Adherium (ASX:ADR) - CEO, Rick Legleiter
CEO, Rick Legleiter
Source: Adherium
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Adherium (ASX:ADR) announces the resignation of its CEO, Rick Legleiter
  • Mr Legleiter has tendered his resignation and provided a six-month notice period as the company transitions to new leadership
  • The Board announced that Lou Panaccio, the current Chairman, will take on the position of Executive Chairman
  • The Board will begin an executive search to fill the CEO position
  • ADR last traded at 5.9 cents

Adherium (ASX:ADR) has announced the resignation of its Chief Executive Officer, Rick Legleiter.

Mr Legleiter has tendered his resignation and provided a six-month notice period as the company transitions to new leadership.

Having joined Adherium in May 2021 amid the challenges of the COVID-19 pandemic, the company praised Mr Legleiter for playing an important role in guiding the company organisation through regulatory filings.

“I staunchly believe our reimbursed digital technology helps respiratory patients live better lives while reducing healthcare costs and I am convinced we have opened the door to success for the company’s commercial strategy,” Mr Legleiter said.

“While leaving for family reasons, I thank shareholders, the Board, my leadership team, and all employees for the honour of serving.”

Lou Panaccio, who currently serves as the company’s Chairman, is set to transition into the role of Executive Chairman, additionally, the Board will conduct an executive search to fill the CEO position.

ADR last traded at 5.9 cents.

ADR by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…